PRAGUE, Czech Republic, April 24, 2018 -- This week at the industry’s premier flow cytometry conference, CYTO 2018, Cytek Biosciences Inc. will be on the show floor highlighting its CytekTM Aurora flow cytometry system with enhanced features. This unique platform has been embraced by researchers around the world since making its debut at CYTO 2017, and the deployments so far have been validating the application flexibility of the Cytek Aurora. From extra-cellular vesicles to highly multiparametric applications beyond what were initially envisioned and more, the breadth of applications being performed on the Cytek Aurora continues to grow.
“At this time last year, we introduced the scientific community to an all-new full spectrum flow cytometer that enables new discoveries and deeper biological insights at an affordable cost,” noted Dr. Wenbin Jiang, CEO of Cytek Biosciences. “Now, Cytek Aurora has been sold into four continents and is at work all over the globe. CYTO 2018 is the perfect place for us to showcase how we have expanded Cytek Aurora’s features and application abilities over the past year and set the stage for future innovations to come.”
Cytek Aurora offers capabilities that go beyond flow cytometry systems that come with a much higher price tag. With a simplified workflow, greater flexibility, and a lower cost of ownership, the Cytek Aurora is the embodiment of Cytek’s mission to make high end, high quality flow cytometry accessible to a larger number of researchers.
Cytek Aurora will be demonstrated at CYTO 2018 in Prague, Czech Republic, from April 28 – May 2 at booth #33. CYTO attendees are also encouraged to learn more about the Cytek Aurora through the following CYTO events and displays:
-
- Wednesday, May 2 – Commercial Tutorial: ‘Expanding Application Capabilities Using Full Spectrum Cytometry’
- Poster: ‘Minimizing the Effects of Spectral Overlap by Unmixing Versus Compensation,’ Program Number: 294. Poster Board Number: B289.
Please visit www.cytekbio.com for more information.
About Cytek Biosciences
Cytek Biosciences Inc. is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. To learn more, visit www.cytekbio.com and follow them on LinkedIn.
Media Contact:
Justine Houston-Brown
Lages & Associates
(949) 453-8080
[email protected]
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/0c0b45d4-94bf-44ef-bcd8-8c3cf3b572ad


HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Bathla Group Hires Administrators as Australia Housing Slump Deepens
Mercer International Stock Surges 45% on C$20 Million Canada Funding
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Nvidia Options Price in $280 Billion Earnings Swing
SK Hynix Shares Fall as Workers Reject Wage Deal
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
OpenAI AI Agent Swarm Behind Hugging Face Hack
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Google Expands Gemini Enterprise With AI Tools for Legal Sector
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 



